Sutro Biopharma | 4: Statement of changes in beneficial ownership of securities-Officer Gerber Hans-Peter
Sutro Biopharma | 10-Q: Q2 2024 Earnings Report
Sutro Biopharma | 8-K: Sutro Biopharma Reports Second Quarter 2024 Financial Results, Business Highlights and Select Anticipated Milestones
Sutro Biopharma | 4: Statement of changes in beneficial ownership of securities-Officer Chung Jane
Sutro Biopharma | 3: Initial statement of beneficial ownership of securities-Director Jagpal Sukhi
Sutro Biopharma | 4: Statement of changes in beneficial ownership of securities-Director Jagpal Sukhi
Sutro Biopharma | 8-K: Current report
Sutro Biopharma | 3: Initial statement of beneficial ownership of securities-Officer Leyman Barbara
Sutro Biopharma | 4: Statement of changes in beneficial ownership of securities-Officer Leyman Barbara
Sutro Biopharma | 4: Statement of changes in beneficial ownership of securities-Director Petree Daniel H
Sutro Biopharma | 8-K: Current report
Sutro Biopharma | 4: Statement of changes in beneficial ownership of securities-Director Wigginton Jon Marc
Sutro Biopharma | 4: Statement of changes in beneficial ownership of securities-Director MATSUI CONNIE
Sutro Biopharma | 4: Statement of changes in beneficial ownership of securities-Director PANEK JAMES P
Sutro Biopharma | 4: Statement of changes in beneficial ownership of securities-Director Lobacki Joseph M
Sutro Biopharma | 4: Statement of changes in beneficial ownership of securities-Director Dybbs Michael
Sutro Biopharma | 4: Statement of changes in beneficial ownership of securities-Director Freund John Gordon
Sutro Biopharma | 4: Statement of changes in beneficial ownership of securities-Director Hunter Heidi
Sutro Biopharma | DEFA14A: Others
Sutro Biopharma | 10-Q: Q1 2024 Earnings Report
No Data
No Data